Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 376Other hematologic neoplasm 94Plasma cell 7Sarcoma 4Tumor-Agnostic 3Thoracic 3Dermatologic 3Myeloid 2Head & Neck 2Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Gemcitabine 301Fluorouracil 295Oxaliplatin 268Bevacizumab 268Capecitabine 233Leucovorin 227pembrolizumab 215Irinotecan 183Cisplatin 142Cetuximab 142Nivolumab 130Paclitaxel 116130-nm albumin-bound paclitaxel 116Sorafenib 86Albumin-Bound Paclitaxel 75regorafenib 64atezolizumab 64Docetaxel 64Folfox protocol 62IFL protocol 61Trastuzumab 54Panitumumab 47durvalumab 46Ramucirumab 43Injections 42Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Rituximab × Gastrointestinal × Clear all
NCT03997968 2024-12-24

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Cyteir Therapeutics, Inc.

Phase 1/2 Completed
169 enrolled
BreastGastrointestinalGynecologicHead & NeckLymphoidPlasma cellSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Lymphoma, Mantle-Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡